Nasdaq or NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of January 2024
Nasdaq or NYSE listed Biotechnology: Biological Products (No Diagnostic Substances) industry Top Companies List by Market Cap as of Jan-05-2024. Nasdaq and NYSE related Biotechnology: Biological Products (No Diagnostic Substances) industry Largest Companies List by Market Cap as of Jan-05-2024
-
World Rank (Jan-05-2024)10,826Market Cap (Jan-05-2024)0.671 Billion USDWorld Rank (Jul-30-2023)12,352Market Cap (Jul-30-2023)0.531 Billion USDWorld Rank (Dec-25-2022)10,106Market Cap (Dec-25-2022)0.731 Billion USDWorld Rank (Jan-07-2022)7,536Market Cap (Jan-07-2022)1.46 Billion USDAnnual Revenue in USD133 Million USDAnnual Net Income in USD-133 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileAlector is a Clinical Stage Biopharmaceutical company developing a broad portfolio of programs designed to empower the brains immune system to fight disease. It is having 78 employees as on 2019. The headquarters is in USA.Company Website
-
Novavax
World Rank (Jan-05-2024)11,359Market Cap (Jan-05-2024)0.613 Billion USDWorld Rank (Jul-30-2023)10,617Market Cap (Jul-30-2023)0.708 Billion USDWorld Rank (Dec-25-2022)9,445Market Cap (Dec-25-2022)0.821 Billion USDWorld Rank (Jan-07-2022)1,955Market Cap (Jan-07-2022)9.58 Billion USDAnnual Revenue in USD1,598 Million USDAnnual Net Income in USD-657 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileNovavax is a Late Stage Biotechnology company that promotes improved global health through the discovery, development and commercialization of innovative vaccines to prevent serious infectious diseases. The company annual revenue is 157.0 million USD and 375 employees as on 2020. The headquarters is in USA.
-
Fusion Pharmaceuticals Inc.
World Rank (Jan-05-2024)11,376Market Cap (Jan-05-2024)0.611 Billion USDWorld Rank (Jul-30-2023)17,315Market Cap (Jul-30-2023)0.229 Billion USDWorld Rank (Dec-25-2022)19,740Market Cap (Dec-25-2022)0.145 Billion USDWorld Rank (Jan-07-2022)18,656Market Cap (Jan-07-2022)0.21 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-78 Million USDAnnual Results for Period EndingDec-2020 ending yearCompany ProfileFusion Pharmaceuticals does research and works on Next-Generation Radiopharmaceuticals for precision medicine. Headquarters is in Canada.Company Website -
Allogene Therapeutics
World Rank (Jan-05-2024)11,801Market Cap (Jan-05-2024)0.570 Billion USDWorld Rank (Jul-30-2023)10,537Market Cap (Jul-30-2023)0.718 Billion USDWorld Rank (Dec-25-2022)9,189Market Cap (Dec-25-2022)0.859 Billion USDWorld Rank (Jan-07-2022)6,446Market Cap (Jan-07-2022)1.92 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-332 Million USDAnnual Results for Period EndingDec-2022 ending yearCompany ProfileAllogene Therapeutics is a Clinical Stage Biotechnology company. It single minded focus on pioneering the development of allogeneic chimeric antigen receptor T cell therapies for cancer and researchers is dedicated to discovery and translational research, development and cell manufacturing. The headquarters is in USA.Company Website -
Anavex Life Sciences
World Rank (Jan-05-2024)12,167Market Cap (Jan-05-2024)0.536 Billion USDWorld Rank (Jul-30-2023)11,175Market Cap (Jul-30-2023)0.641 Billion USDWorld Rank (Dec-25-2022)10,700Market Cap (Dec-25-2022)0.659 Billion USDWorld Rank (Jan-07-2022)8,577Market Cap (Jan-07-2022)1.18 Billion USDAnnual Revenue in USD0 Million USDAnnual Net Income in USD-48 Million USDAnnual Results for Period EndingSep-2022 ending yearCompany ProfileAnavex Life Sciences is a person-focused, biopharmaceutical company dedicated to therapeutic discovery and development of targeted CNS treatments. The headquarters is in USA.Company Website -
Voyager Therapeutics
World Rank (Jan-05-2024)12,897Market Cap (Jan-05-2024)0.477 Billion USDWorld Rank (Jul-30-2023)14,213Market Cap (Jul-30-2023)0.395 Billion USDWorld Rank (Dec-25-2022)17,639Market Cap (Dec-25-2022)0.215 Billion USDWorld Rank (Jan-07-2022)22,338Market Cap (Jan-07-2022)0.11 Billion USDAnnual Revenue in USD171 Million USDAnnual Net Income in USD37 Million USDAnnual Results for Period EndingDec-2020 ending yearCompany Website -
MeiraGTx Holdings
World Rank (Jan-05-2024)13,314Market Cap (Jan-05-2024)0.446 Billion USDWorld Rank (Jul-30-2023)14,767Market Cap (Jul-30-2023)0.362 Billion USDWorld Rank (Dec-25-2022)16,414Market Cap (Dec-25-2022)0.269 Billion USDWorld Rank (Jan-07-2022)9,687Market Cap (Jan-07-2022)0.96 Billion USDAnnual Revenue in USD37 Million USDAnnual Net Income in USD-79 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileMeiraGTx Holdings is a Clinical Stage Gene Therapy company. It is focused on developing potentially curative treatments for patients living with serious diseases. The company annual revenue is 5.1 million USD and 155 full employees as on 2019. The headquarters is in USA.Company Website -
iTeos Therapeutics Inc.
World Rank (Jan-05-2024)13,965Market Cap (Jan-05-2024)0.400 Billion USDWorld Rank (Jul-30-2023)12,768Market Cap (Jul-30-2023)0.499 Billion USDWorld Rank (Dec-25-2022)10,597Market Cap (Dec-25-2022)0.669 Billion USDWorld Rank (Jan-07-2022)7,393Market Cap (Jan-07-2022)1.52 Billion USDAnnual Revenue in USD344 Million USDAnnual Net Income in USD214 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileiTeos Therapeutics is a Clinical Stage Biopharmaceutical Company pioneering the discovery and development of a new generation of highly differentiated immuno oncology therapeutics for patients. It innovative pipeline includes two clinical stage programs targeting novel, validated immuno oncology pathways designed to build on prior learnings in the field to have differentiated pharmacological and clinical profiles. The headquarters is in USA.Company Website -
Fate Therapeutics
World Rank (Jan-05-2024)14,336Market Cap (Jan-05-2024)0.379 Billion USDWorld Rank (Jul-30-2023)13,932Market Cap (Jul-30-2023)0.414 Billion USDWorld Rank (Dec-25-2022)8,052Market Cap (Dec-25-2022)1.070 Billion USDWorld Rank (Jan-07-2022)3,499Market Cap (Jan-07-2022)4.61 Billion USDAnnual Revenue in USD55 Million USDAnnual Net Income in USD-212 Million USDAnnual Results for Period EndingDec-2021 ending yearCompany ProfileFate Therapeutics is a Clinical Stage Biopharmaceutical company. The company is dedicated to the development of next generation cellular immunotherapies for cancer and immune disorders. The headquarters is in USA.
Company Website -
Orchard Therapeutics
World Rank (Jan-05-2024)14,416Market Cap (Jan-05-2024)0.373 Billion USDWorld Rank (Jul-30-2023)22,193Market Cap (Jul-30-2023)0.091 Billion USDWorld Rank (Dec-25-2022)25,462Market Cap (Dec-25-2022)0.048 Billion USDWorld Rank (Jan-07-2022)20,128Market Cap (Jan-07-2022)0.16 Billion USDCompany ProfileOrchard Therapeutics is Biotechnology sector company with headquarters is in UK.Company Website